Angiogenic factor expression in hepatic cirrhosis.
Alexandra Giatromanolaki1, Stamatia Kotsiou, Michael I Koukourakis
1Department of Pathology, Democritus University of Thrace Medical School, P.O. Box 12, 68100 Alexandroupolis, Greece.
Mediators of Inflammation
|May 15, 2007
Summary
Hepatic cirrhosis fibrosis is unclear. Regenerative hepatocytes express angiogenic factors like VEGF, TP, bFGF, and aFGF, potentially driving fibrous band development in liver fibrosis.
Area of Science:
- Hepatology
- Pathology
- Molecular Biology
Background:
- The mechanisms underlying fibrosis in hepatic cirrhosis are not fully understood.
- Investigating the role of angiogenic factors in the fibrotic process is crucial for understanding liver disease progression.
Purpose of the Study:
- To examine the role of angiogenic factors in the fibrotic process of hepatic cirrhosis.
- To investigate the expression of vascular endothelial growth factor (VEGF), thymidine phosphorylase (TP), and fibroblast growth factors (FGFs) in cirrhotic liver tissues.
Main Methods:
- Studied 55 cirrhotic liver samples.
- Assessed fibroblast proliferation and expression of VEGF, TP, bFGF, and aFGF in fibroblasts and hepatic cells using immunohistochemistry.
Main Results:
- Angiogenic and fibrogenic factors (VEGF, TP, bFGF, aFGF) were expressed in regenerative hepatocytes.
- These factors were not found in fibroblasts within diffuse hepatic fibrosis.
- Thymidine phosphorylase (TP), a factor promoting oxidative stress, was also expressed in hepatocytes.
Conclusions:
- Hepatocyte-derived angiogenic factors and oxidative stress factors (TP) may contribute to the formation of fibrous bands in hepatic cirrhosis.
- This suggests a potential pathway for therapeutic intervention in liver fibrosis.
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...